{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:06:23Z","timestamp":1793199983256,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01123-z","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T04:05:11Z","timestamp":1688184311000},"page":"3527-3538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical features and relapse risks factors of IgG4 related disease: a single-center retrospective study"],"prefix":"10.1007","volume":"23","author":[{"given":"Xinhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"issue":"6","key":"1123_CR1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00296-021-04848-w","volume":"41","author":"NN Tarte","year":"2021","unstructured":"Tarte NN, Ravipati CS, Leondela Rocha JA, Rinker E, Patel NJ. IgG4-related disease with multiorgan involvement: a case-based review. Rheumatol Int. 2021;41(6):1169\u201374. https:\/\/doi.org\/10.1007\/s00296-021-04848-w.","journal-title":"Rheumatol Int"},{"issue":"709","key":"1123_CR2","first-page":"1870","volume":"16","author":"Y Liard","year":"2020","unstructured":"Liard Y, Nigolian H, Lobrinus JA, et al. ENT and head and neck manifestations of the IgG4-related disease. Rev Med Suisse. 2020;16(709):1870\u20135.","journal-title":"Rev Med Suisse"},{"issue":"10","key":"1123_CR3","doi-asserted-by":"publisher","first-page":"300060520959214","DOI":"10.1177\/0300060520959214","volume":"48","author":"Xu Cheng","year":"2020","unstructured":"Cheng Xu, Yongmei H. Immunoglobulin G4-related sclerosing cholangitis mimicking cholangiocarcinoma: a case report and literature review. J Int Med Res. 2020;48(10):300060520959214. https:\/\/doi.org\/10.1177\/0300060520959214.","journal-title":"J Int Med Res"},{"key":"1123_CR4","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.jtauto.2020.100074","volume":"4","author":"A Floreani","year":"2020","unstructured":"Floreani A, Okazaki K, Uchida K, Gershwin ME. IgG4-related disease: changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun. 2020;4:100074. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100074.","journal-title":"J Transl Autoimmun"},{"issue":"7","key":"1123_CR5","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688\u201399. https:\/\/doi.org\/10.1002\/art.39132.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1123_CR6","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/rheumatology\/keaa651","volume":"60","author":"H Lu","year":"2021","unstructured":"Lu H, Teng F, Zhang P, et al. Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patients. Rheumatology. 2021;60(6):2635\u201346. https:\/\/doi.org\/10.1093\/rheumatology\/keaa651.","journal-title":"Rheumatology"},{"issue":"3","key":"1123_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3760\/cma.j.cn112138-20200803-00726","volume":"60","author":"W Zhang","year":"2021","unstructured":"Zhang W, Dong LL, Zhu J, et al. Chinese expert consensus on the diagnosis and treatment of IgG 4 related diseases. Zhonghua Nei Ke Za Zhi. 2021;60(3):192\u2013206. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20200803-00726.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"8","key":"1123_CR8","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/rheumatology\/kez669","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zeng Q, Zhu L, et al. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort. Rheumatology. 2020;59(8):2115\u201323. https:\/\/doi.org\/10.1093\/rheumatology\/kez669.","journal-title":"Rheumatology"},{"issue":"6","key":"1123_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/apm.12845","volume":"126","author":"JR Bledsoe","year":"2018","unstructured":"Bledsoe JR, Della-Torre E, Rovati L, Deshpande V. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS. 2018;126(6):459\u201376. https:\/\/doi.org\/10.1111\/apm.12845.","journal-title":"APMIS"},{"issue":"9","key":"1123_CR10","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheum. 2015;67(9):2466\u201375. https:\/\/doi.org\/10.1002\/art.39205.","journal-title":"Arthritis Rheum"},{"issue":"15","key":"1123_CR11","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine. 2015;94(15):e680. https:\/\/doi.org\/10.1097\/MD.0000000000000680.","journal-title":"Medicine"},{"issue":"11","key":"1123_CR12","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology. 2015;54(11):1982\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/kev203.","journal-title":"Rheumatology"},{"issue":"2","key":"1123_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.semarthrit.2019.06.018","volume":"50","author":"J Tang","year":"2020","unstructured":"Tang J, Cai S, Ye C, Dong L. Biomarkers in IgG4-related disease: a systematic review. Semin Arthritis Rheum. 2020;50(2):354\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.018.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1123_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro C, Ramirez GA, Bozzolo EP, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45(2):135\u201345. https:\/\/doi.org\/10.3109\/03009742.2015.1055796.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1123_CR15","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","volume":"7","author":"F Yunyun","year":"2017","unstructured":"Yunyun F, Yu C, Panpan Z, et al. Efficacy of Cyclophosphamide treatment for immunoglobulin G4 related disease with addition of glucocorticoids. Sci Rep. 2017;7(1):6195. https:\/\/doi.org\/10.1038\/s41598-017-06520-5.","journal-title":"Sci Rep"},{"issue":"11","key":"1123_CR16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/1756-185X.13949","volume":"23","author":"K Phaopraphat","year":"2020","unstructured":"Phaopraphat K, Ngamjanyaporn P, Narongroeknawin P, Kasitanon N, Katchamart W. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease. Int J Rheum Dis. 2020;23(11):1468\u201373. https:\/\/doi.org\/10.1111\/1756-185X.13949.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"1123_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","volume":"91","author":"M Ebbo","year":"2012","unstructured":"Ebbo M, Daniel L, Pavic M, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine. 2012;91(1):49\u201356. https:\/\/doi.org\/10.1097\/MD.0b013e3182433d77.","journal-title":"Medicine"},{"issue":"9","key":"1123_CR18","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466\u201375. https:\/\/doi.org\/10.1002\/art.39205.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1123_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/rheumatology\/key397","volume":"58","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang P, Zhang X, Lin W, Tang H, Li J. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients. Rheumatology. 2019;58(5):820\u201330. https:\/\/doi.org\/10.1093\/rheumatology\/key397.","journal-title":"Rheumatology"},{"issue":"3","key":"1123_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/rheumatology\/kez280","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xue M, Wang Z, et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Rheumatology. 2020;59(3):634\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/kez280.","journal-title":"Rheumatology"},{"issue":"6","key":"1123_CR21","first-page":"1206","volume":"38","author":"P Zhang","year":"2020","unstructured":"Zhang P, Han X, Li J, et al. IgG4-related fibrosing mediastinitis: clinical presentation, treatment efficacy and comparison with IgG4-RD without fibrosing mediastinitis. Clin Exp Rheumatol. 2020;38(6):1206\u201314.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1123_CR22","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.1038\/s41598-021-89844-7","volume":"11","author":"Q Zeng","year":"2021","unstructured":"Zeng Q, Gao J, Zhang X, et al. Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients. Sci Rep. 2021;11(1):10397. https:\/\/doi.org\/10.1038\/s41598-021-89844-7.","journal-title":"Sci Rep"},{"issue":"1","key":"1123_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13075-021-02489-9","volume":"23","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Mou D, Wang Z, et al. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single- center experience in China. Arthritis Res Ther. 2021;23(1):98. https:\/\/doi.org\/10.1186\/s13075-021-02489-9.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1123_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13075-021-02527-6","volume":"23","author":"H Matsumoto","year":"2021","unstructured":"Matsumoto H, Fujita Y, Matsuoka N, et al. Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD). Arthritis Res Ther. 2021;23(1):148. https:\/\/doi.org\/10.1186\/s13075-021-02527-6.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1123_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00535-006-1868-0","volume":"41","author":"K Okazaki","year":"2006","unstructured":"Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41(7):626\u201331. https:\/\/doi.org\/10.1007\/s00535-006-1868-0.","journal-title":"J Gastroenterol"},{"key":"1123_CR26","doi-asserted-by":"publisher","first-page":"787422","DOI":"10.3389\/fimmu.2021.787422","volume":"12","author":"M Maslinska","year":"2022","unstructured":"Maslinska M, Dmowska-Chalaba J, Jakubaszek M. The role of IgG4 in autoimmunity and rheumatic diseases. Front Immunol. 2022;12:787422. https:\/\/doi.org\/10.3389\/fimmu.2021.787422.","journal-title":"Front Immunol"},{"issue":"4","key":"1123_CR27","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.1111\/aos.13968","volume":"97","author":"S Abad","year":"2019","unstructured":"Abad S, Martin A, H\u00e9ran F, et al. IgG4-related disease in patients with idiopathic orbital inflammation syndrome: data from the French SIOI prospective cohort. Acta Ophthalmol. 2019;97(4):e648\u201356. https:\/\/doi.org\/10.1111\/aos.13968.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"1123_CR28","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466\u201375. https:\/\/doi.org\/10.1002\/art.39205.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1123_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","volume":"19","author":"K Yamada","year":"2017","unstructured":"Yamada K, Yamamoto M, Saeki T, et al. New clues to the nature of immunoglobulin G4-related disease:a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19(1):262. https:\/\/doi.org\/10.1186\/s13075-017-1467-x.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1123_CR30","first-page":"771","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62(1):771\u20136.","journal-title":"Gut"},{"issue":"12","key":"1123_CR31","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","volume":"62","author":"W Yiwen","year":"2013","unstructured":"Yiwen W, Zheng Z, Dai G, et al. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: a randomized clinical trial. Gut. 2013;62(12):1771\u20136. https:\/\/doi.org\/10.1136\/gutjnl-2012-303617.","journal-title":"Gut"},{"issue":"9","key":"1123_CR32","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/art.39686","volume":"68","author":"H Sekiguchi","year":"2016","unstructured":"Sekiguchi H, Horie R, Kanai M, Suzuki R, Yi ES, Ryu JH. IgG4-related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 2016;68(9):2290\u20139. https:\/\/doi.org\/10.1002\/art.39686.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1123_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/1751-2980.12708","volume":"20","author":"M Miki","year":"2019","unstructured":"Miki M, Fujimori N, Oono T, et al. Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: a single-center retrospective study of 115 patients. J Dig Dis. 2019;20(3):152\u20138. https:\/\/doi.org\/10.1111\/1751-2980.12708.","journal-title":"J Dig Dis"},{"issue":"5","key":"1123_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/joim.12942","volume":"286","author":"Y Peng","year":"2019","unstructured":"Peng Y, Li JQ, Zhang PP, et al. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study. J Intern Med. 2019;286(5):542\u201352. https:\/\/doi.org\/10.1111\/joim.12942.","journal-title":"J Intern Med"},{"issue":"1","key":"1123_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-021-024","volume":"23","author":"L Peng","year":"2021","unstructured":"Peng L, Lu H, Zhou J, et al. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study. Arthritis Res Ther. 2021;23(1):102. https:\/\/doi.org\/10.1186\/s13075-021-024.","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01123-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:23:32Z","timestamp":1698783812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01123-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01123-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with Declaration Helsinki. The ethics committee waived the requirement for informed consent because of the retrospective nature of the study. But the protocol was approved by the Ethics Committee of <i>the First Hospital of China Medical University<\/i> ([2022]20).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}